NCT01351870View on ClinicalTrials.gov

Hyperfractionated Versus Conventionally Fractionated Radiotherapy in Standard Risk Medulloblastoma (PNET4)

PHASE3CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

April 30, 2004

Primary Completion Date

December 31, 2008

Study Completion Date

March 31, 2020

Conditions
Medulloblastoma
Interventions
RADIATION

Standard Fractionation Regimen

"1.8 Gy daily, 5 fractions per week~Cranio-spinal axis:~23.4 Gy in 13 fractions of 1.8 Gy~Posterior fossa:~30.6 Gy in 17 fractions of 1.8 Gy"

RADIATION

Hyperfractionated Radiotherapy

"1 Gy b.d. (minimum interval between fractions 8 hours). 10 fractions per week~Craniospinal axis:~36 Gy in 36 fractions of 1 Gy~Posterior fossa:~24 Gy in 24 fractions of 1 Gy~Tumour Bed:~8 Gy in 8 fractions of 1 Gy"

Trial Locations (1)

75005

Institut Curie, Paris

All Listed Sponsors
lead

Institut Curie

OTHER

NCT01351870 - Hyperfractionated Versus Conventionally Fractionated Radiotherapy in Standard Risk Medulloblastoma (PNET4) | Biotech Hunter | Biotech Hunter